Skip to content

GENETIC LEVERAGE

Active
Private limited company (pre-2019)founded 199828 yrs activeAmaryllisstraat 1, 9090 Merelbeke-Melle, BelgiumKBO/BCE: BE 0464.142.030
Summary

GENETIC LEVERAGE has been active since 1998 and the Belgian State Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €6,112 and a net result of -€2,816. Equity is shrinking by ~32.8% per year and would, assuming unchanged policy, indicatively turn negative around fiscal year 2026. The computed 12-month bankruptcy probability is 1.2% (low).

Checked score

Score 2025
Axes · tick = 2024
Profitability28▲+25
Solvency33▼-3
Growth32=
Track record100
Bankruptcy probability, 12 months
1.2% Low
0%0.5%1.5%4%10%≥ 25%
Credit check for your own amount and term

Show the recommended maximum : and see how the verdict changes with amount, term and advance.

Signals

Five signals. The signal on the left, the evidence on the right.
−lowers risk+raises risk○neutral
raises risk · No NACE activity registered
No NACE activity is registered in the KBO, which is more common among companies that later fail.
KBO · activities
lowers risk · Long track record
A company with a long track record statistically fails less often than a young one.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 28 years 0 30 y
raises risk · Annual accounts: weaker financial profile
The latest annual accounts show a weaker profile in solvency, result or liquidity than companies that stay afloat.
NBB · annual accounts 2025
Solvency, return and age of the figures
Solvency
8.3%
Return on assets
-3.8%
Age of the figures
19 mo
raises risk · Persistent losses
Two consecutive loss-making years (2024 and 2025); equity is also lower. May indicate structural pressure on profitability.
NBB · annual accounts 2025
Net result per financial year
19202122232425
2019 to 2025 · latest year -€2,816
neutral · Filed after the deadline
The financial year that closed on 28-02-2025 was due by 30-09-2025 and was filed on 28-11-2025, 59 days later. For context: 47% of the Belgian market files late and the whole 1-to-90-day band measures 2.0% abnormal legal state against a 1.66% average. We show this as a fact and do not score it.
NBB · 10 filings
Deviation from the deadline
2025
59 d late
2024
6 d late
2023
44 d late
2022
409 d late
2021
776 d late
2020
228 d late
2019
458 d late
← before the deadline after the deadline →
tick = median of all Belgian filings

This company filed its last 7 accounts on average 283 days after the deadline; the Belgian median for financial year 2024 is 4 days before the deadline, and 38% of all filings were late.

Checked, nothing found (1)
neutral · No strike-offs in the KBO publications
We found no ex-officio strike-off or cessation. Our series starts in 2021 and has gaps, so this is not a confirmation that there is nothing.
KBO publications · our coverage

History

On 15 September 1998, GENETIC LEVERAGE was incorporated.1 Total assets went from EUR 226,658 in 2019 to EUR 73,556 in 2025.2

  1. 1Crossroads Bank for Enterprises
  2. 2National Bank, annual accounts 2019 and 2025

Go further with this company

Is this your company? See how customers and banks see it.

Investigating this company? Keep it with today's facts in a case file.

Financials · fiscal year 2025, micro schema

Equity
€6,112▼ 31.5%
2024 · €8,928
Total assets
€73,556▼ 6.6%
2024 · €78,717
Net result
-€2,816▲ 74.0%
2024 · -€10,816
Working capital
€67,702▼ 4.0%
2024 · €70,518
Trend over the years

Click a name to add, emphasise or remove a line.

Every figure with its change against the fiscal year before
favourable unfavourable
Line20212022202320242025
Operating result-€4,874▲ 8.6%-€4,802▲ 1.5%-€2,759▲ 42.5%-€10,759▼ 290%-€2,637▲ 75.5%
Net result-€4,872▲ 7.9%-€19,602▼ 302%-€12,691▲ 35.3%-€10,816▲ 14.8%-€2,816▲ 74.0%
Equity€52,038▼ 8.6%€32,436▼ 37.7%€19,744▼ 39.1%€8,928▼ 54.8%€6,112▼ 31.5%
Total assets€193,368▼ 0.2%€161,343▼ 16.6%€150,714▼ 6.6%€78,717▼ 47.8%€73,556▼ 6.6%
Debt€141,331▲ 3.3%€128,907▼ 8.8%€130,970▲ 1.6%€69,789▼ 46.7%€67,444▼ 3.4%
Working capital€147,627▼ 12.9%€94,026▼ 36.3%€81,334▼ 13.5%€70,518▼ 13.3%€67,702▼ 4.0%
Turnover and EBIT margin not published: the abbreviated or micro schema does not require them.
Result per fiscal year
Operating resultNet result
-€20,000-€15,000-€10,000-€5,000€0Operating result 2021: -€4,874-€4,874Net result 2021: -€4,872-€4,872Operating result 2022: -€4,802-€4,802Net result 2022: -€19,602-€19,602Operating result 2023: -€2,759-€2,759Net result 2023: -€12,691-€12,691Operating result 2024: -€10,759-€10,759Net result 2024: -€10,816-€10,816Operating result 2025: -€2,637-€2,637Net result 2025: -€2,816-€2,81620212022202320242025-€15,000-€10,000-€5,000€0Operating result 2023: -€2,759-€2,760Net result 2023: -€12,691-€12,700Operating result 2024: -€10,759-€10,800Net result 2024: -€10,816-€10,800Operating result 2025: -€2,637-€2,640Net result 2025: -€2,816-€2,820202320242025
The operating result stays negative: a loss of €2,637 in 2025 against €10,759 in 2024; the loss shrinks.
Balance-sheet composition
2025 in colour, 2024 as the grey bar beneath
Equity and liabilities €73,556
Equity €6,112 ▼ 31.5%
Debt €67,444 ▼ 3.4%
Debt's share of the balance-sheet total rises from 88.7% to 91.7%. Equity and debt are lower.
Key figures and ratios
2025 value · change against 2024
Current ratio
12.56▲
2024 · 9.60
Debt to equity
11.03▲
2024 · 7.82
ROE
-46.1%▲
2024 · -121.2%
ROA
-3.8%▲
2024 · -13.7%
Debt ≤ 1 year
€5,854▼
2024 · €8,199
Debt > 1 year
€61,590=
2024 · €61,590
Green means a favourable move, even when the figure itself falls: as with debt or debt to equity.

Peer companies

Historical observation

Of the 974 companies that looked in July 2024 the way this one looks now, 2.1% went bankrupt within 24 months and 93% are still going.

  • Micro
  • 20 years or older
  • solvency under 10%
  • a small loss
2.1% went bankrupt
4.5% stopped otherwise
93% still going

A further 0.8% stopped, but we cannot tell whether within those 24 months.

For this company itself Checked computes a bankruptcy probability of 1.2% over twelve months; the group does not contradict it.

How reliable is this rule?

Tested on the year before, without using that year itself: the groups of July 2023 gave each of the 497,662 companies of July 2024 its group's bankruptcy share. Expected: 1.5%; actually bankrupt within 24 months: 1.6%.

The companies in ten equal groups, from lowest to highest expected share.
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.4%
3 0.5% 0.5%
4 0.6% 0.7%
5 0.8% 0.9%
6 1.2% 1.3%
7 1.5% 1.7%
8 1.7% 1.7%
9 2.7% 2.8%
10 5.3% 5.7%

The rule ranks well: a company that went bankrupt got a higher share than one that kept going in 75% of comparisons. The level follows the economy: in a year with more bankruptcies, the actual share is higher than the year before.

An observation about 974 comparable companies, not a prediction for this company. The sector does not count: the register keeps no sector for companies that stopped, so it would make the outcome look better than it was.

Annual accounts
Filed annual accounts As filed with the NBB · 2025 against 2024 · 29 lines
Balance sheet Code20242025
Assets
Total assets20/58€78,717€73,556▼
Current assets29/58€78,717€73,556▼
Cash at bank and in hand54/58€78,717€73,556▼
Equity and liabilities
Total equity and liabilities10/49€78,717€73,556▼
Equity10/15€8,928€6,112▼
Contributions10/11€6,197€6,197=
Capital10€6,197€6,197=
Issued capital100€18,592€18,592=
Uncalled capital101€12,395€12,395=
Reserves13€184,924€184,924=
Distributable reserves133€184,924€184,924=
Profit (loss) carried forward14-€182,193-€185,009▼
Amounts payable17/49€69,789€67,444▼
Amounts payable after more than one year17€61,590€61,590=
Financial debts170/4€61,590€61,590=
Amounts payable within one year42/48€8,199€5,854▼
Trade debts44€2,526€182▼
Suppliers440/4€2,526€182▼
Other amounts payable47/48€5,673€5,673=
Income statement Code20242025
Other operating charges640/8€939€678▼
Gross operating margin9900-€9,821-€1,959▲
Operating profit (loss)9901-€10,759-€2,637▲
Financial charges65/66B€57€179▲
Recurring financial charges65€57€179▲
Profit (loss) for the period before taxes9903-€10,816-€2,816▲
Profit (loss) for the period9904-€10,816-€2,816▲
Profit (loss) for the period to be appropriated9905-€10,816-€2,816▲
Appropriation of the result
Profit (loss) to be appropriated9906-€182,193-€185,009▼
Profit (loss) brought forward from the previous period14P-€171,377-€182,193▼

The notes to these accounts (3 items: statements of assets and debts, cost breakdowns, rights and commitments) are not shown here.

Line20212022202320242025Change
Other operating charges640/8€194€2,290€2,229€939€678▼ 27.8%
Gross operating margin9900-€4,679-€2,512-€530-€9,821-€1,959▲ 80.0%
Operating profit (loss)9901-€4,874-€4,802-€2,759-€10,759-€2,637▲ 75.5%
Financial income75/76B€2-----
Recurring financial income75€2-----
Financial charges65/66B€0€52€702€57€179▲ 214%
Recurring financial charges65€0€52€702€57€179▲ 214%
Profit (loss) for the period before taxes9903-€4,872-€4,853-€3,461-€10,816-€2,816▲ 74.0%
Income taxes67/77-€14,749€9,231---
Profit (loss) for the period9904-€4,872-€19,602-€12,691-€10,816-€2,816▲ 74.0%
Profit (loss) for the period to be appropriated9905-€4,872-€19,602-€12,691-€10,816-€2,816▲ 74.0%
Line20212022202320242025Change
Assets
Total assets20/58€193,368€161,343€150,714€78,717€73,556▼ 6.6%
Current assets29/58€193,368€161,343€150,714€78,717€73,556▼ 6.6%
Amounts receivable within one year40/41€14,749-----
Other amounts receivable41€14,749-----
Cash at bank and in hand54/58€178,620€161,343€150,714€78,717€73,556▼ 6.6%
Equity and liabilities
Total equity and liabilities10/49€193,368€161,343€150,714€78,717€73,556▼ 6.6%
Equity10/15€52,038€32,436€19,744€8,928€6,112▼ 31.5%
Contributions10/11€6,197€6,197€6,197€6,197€6,197=
Capital10€6,197€6,197€6,197€6,197€6,197=
Issued capital100€18,592€18,592€18,592€18,592€18,592=
Uncalled capital101€12,395€12,395€12,395€12,395€12,395=
Reserves13€184,924€184,924€184,924€184,924€184,924=
Distributable reserves133€184,924€184,924€184,924€184,924€184,924=
Profit (loss) carried forward14-€139,083-€158,685-€171,377-€182,193-€185,009▼ 1.5%
Amounts payable17/49€141,331€128,907€130,970€69,789€67,444▼ 3.4%
Amounts payable after more than one year17€95,590€61,590€61,590€61,590€61,590=
Financial debts170/4€95,590€61,590€61,590€61,590€61,590=
Amounts payable within one year42/48€45,741€67,318€69,380€8,199€5,854▼ 28.6%
Trade debts44€4,701€6,913€8,163€2,526€182▼ 92.8%
Suppliers440/4€4,701€6,913€8,163€2,526€182▼ 92.8%
Other amounts payable47/48€41,040€60,405€61,218€5,673€5,673=
Line20212022202320242025Change
Profit (loss) for the period9904-€4,872-€19,602-€12,691-€10,816-€2,816▲ 74.0%
Operating cash flow (approximation)-€4,872-€19,602-€12,691-€10,816-€2,816▲ 74.0%
Change in cash--€17,276-€10,629-€71,998-€5,161▲ 92.8%

Simplified and derived: a Belgian filing has no cash-flow statement, so these rows come from the income statement and the balance-sheet moves.

Download as CSV

Timeline · acts, filings and financial milestones

2025
28-11
NBB filing Annual accounts filed
fiscal year 2025 · micro schema · 59 days late
2024
06-10
NBB filing Annual accounts filed
fiscal year 2024 · abbreviated schema · 6 days late
29-02
Financial Liquidity quadruplescurrent ratio 9.60
Current ratio from 2.17 to 9.60; short-term debt falls from €69,380 to €8,199.
2023
15-11
NBB filing Annual accounts filed
fiscal year 2021 · abbreviated schema · 776 days late
13-11
NBB filing Annual accounts filed
fiscal year 2023 · abbreviated schema · 44 days late
13-11
NBB filing Annual accounts filed
fiscal year 2022 · abbreviated schema · 409 days late
2022
28-02
Financial Weakest financial yearnet -€19,602
Net result drops to -€19,602, the lowest in the series; recovery starts the following year.
2021
14-05
NBB filing Annual accounts filed
fiscal year 2020 · abbreviated schema · 228 days late
2020
31-12
NBB filing Annual accounts filed
fiscal year 2019 · abbreviated schema · 458 days late
2019
26-04
NBB filing Annual accounts filed
fiscal year 2018 · abbreviated schema · 208 days late
19-04
NBB filing Annual accounts filed
fiscal year 2017 · abbreviated schema · 566 days late
19-04
NBB filing Annual accounts filed
fiscal year 2016 · abbreviated schema · 933 days late
Financial milestoneNBB filingFinancial milestones sit on the fiscal year-end date, not the filing date.
0 of 1 act read
About the unread acts

We know of 1 Belgian State Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.

Have them read with priority Sign in to place this company at the front of the reading queue.

Directors · office · real estate

Directors
1 act for this company is in the Belgian State Gazette, of which we have read 0. We have therefore not extracted its directors from those acts yet.
Location & real-estate footprint
Registered office, Merelbeke-Melle · 1 establishment unit since 1998
seat establishment The establishment unit on the map
Ground area
757 m²
Building footprint
242 m²
Volume, LiDAR
1,055 m³
Parcel 44402A0162/00L005, Flanders · tallest building 8.3 m, ±1 floor. Linked by address, not a title deed.
1 establishment unit
Amaryllisstraat 1, 9090 Merelbeke-Melle
Insurance, reinsurance and pension funding, except compulsory social security
since 19982.088.379.613
1 parcel
Flanders 1 (100%)
Parcel (capakey) Region Area Buildings Height / fl.
44402A0162/00L005 Flanders 757 m² 1 · 242 m² 8.3 m · 1 fl.
Linked by address, not proof of ownership
Good to know
1 of 1 parcel with an exact address match; the rest are indicative.
Linked through address data, this is not proof of ownership.

Identification & contact

Identification
Legal formPrivate limited company (pre-2019)
Founded15-09-1998
Fiscal year end28-02
Abbreviation NL GENLEVER
E-invoicing
Reachable via Peppol
Peppol ID 0208:0464142030
Also 9925:BE0464142030
Registered 15-01-2026

Register as of 27 September 2026 · Peppol Directory

Scores and ratios are computed by Checked and are not a credit decision.